From: Qualitative assessment of innovations in healthcare provision
Step | Therapeutic innovation | Example |
---|---|---|
I | Preliminary data confirm optimized application of a therapeutic procedure. Only data on effect and safety from clinical studies are available. | Improved tolerance, lower cost, or easier application of therapeutic procedures. |
II | Therapeutic benefit can be expected under everyday conditions due to a weak correlation of surrogate parametersa with desired endpoints. | Reduction of tumor size after chemotherapy with unknown influence on quality of life or survival. |
III | Therapeutic benefit is confirmed under everyday conditions by surrogate parameters which correlate highly with the desired endpoint(s) or achievement of endpoints. | Improvement in a defined area of quality of life or survival is confirmed. |